Healthcare
Financial summary
Comparable pricing
109% above marketComparable Healthcare businesses sell at a median of 2.9x SDE, based on 705 listings. This one asks 6.1x, about 109% above that median. At the comparable median it would price ~$1.9M.Methodology refines over time.Comparable Healthcare businesses sell around $1.9M vs this $4.0M ask.
Methodology refines over time.
SBA financeability
Businesses in ambulatory health care are commonly SBA-financed. The figures below are the industry-category norm from SBA 7(a)/504 lending, a gauge of how financeable a deal like this tends to be.
Ambulatory Health Care benchmarks
Typical SBA leverage
70%
Industry charge-off
0.9%
Common term
10 yr
Median loan
$215,000
Active lenders in this category: The Huntington National Bank, Live Oak Banking Company, Newtek Bank, National Association.
Based on 25,465 SBA loans · source: SBA 7(a)/504 FOIA, as of 2026Q1 · industry-category level.
Detailed information
high SDE margin and strong SDE.
Linked page lives on the broker site, not on OpenAcquisitions.
Key points
Business description
Emerging Clinical Diagnostics Laboratory – Built for Scale | $4–$5M Revenue Growth Potential This is a rare opportunity to acquire a fully credentialed clinical medical laboratory in its early growth stage, strategically positioned to scale to $4–$5 million in annual revenue within the next 24 months under focused business development and payer expansion. Importantly, this is not a startup — the lab is fully operational with infrastructure, licensing, equipment, and compliance foundations already in place. Replicating this build-out from scratch would conservatively exceed $4 million in capital investment, making this a true replacement-cost acquisition with substantial upside. Business Overview This clinical laboratory provides a wide range of diagnostic testing services used by healthcare providers to diagnose, monitor, and screen for health conditions. The lab is: Registered with an active NPI (National Provider Identifier) Operating under CLIA certification Approved to perform regulated clinical laboratory testing The platform is structured for expansion rather than stabilization, presenting a growth-oriented acquisition opportunity. Services & Capabilities The lab currently offers a broad testing menu, including: Genetic and molecular diagnostics Routine clinical testing Clinical toxicology Allergy testing COVID-19 testing Regulatory approvals allow testing across multiple disciplines, including: Bacteriology Clinical chemistry Immunology (serology) Endocrinology Hematology Toxicology Urinalysis Virology This diversified testing capability supports scalability across multiple provider verticals. Clinical Credentials The laboratory team includes: Board-certified pathologists Ph.D.-level professionals in molecular diagnostics Qualified clinical laboratory personnel The lab emphasizes competitive turnaround times and flexible provider ordering/reporting systems, creating a scalable, provider-facing platform. Location & Market Located in Central New Jersey , servicing healthcare providers throughout New York and New Jersey — two of the most regulated and high-value healthcare markets in the country. Growth Opportunity – Asset Sale This lab is operationally early-stage but fully built structurally. Key growth drivers include: Expansion of provider network Increased specimen volume Strategic payer contracting Sales force deployment Targeted specialty testing expansion With proper capitalization and business development, the platform is positioned for significant near-term revenue growth. Ideal Buyer This opportunity is ideal for: Strategic laboratory operators Healthcare investors Private equity groups Physician groups seeking vertical integration Healthcare consolidators This is a confidential offering . Detailed financials, payer mix, equipment schedules, and regulatory documentation are available upon signed NDA .
See something off?
